Appropriate implantable cardioverter-defibrillator interventions in cardiac resynchronization therapy-defibrillator (CRT-D) patients undergoing device replacement: time to downgrade from CRT-D to CRT-pacemaker? Insights from real-world clinical practice in the DECODE CRT-D analysis.
Cardiac resynchronization therapy (CRT) device replacement considerations: upgrade or downgrade? A complex decision in the current clinical setting.
Nakou ES, Simantirakis EN, Kallergis EM, Nakos KS, Vardas PE.
Europace. 2017 May 1;19(5):705-711. doi: 10.1093/europace/euw317.
Downgrade from CRT-D to CRT-P at time of generator replacement: a true clinical conundrum or just an academic debate?
Clarke JD, Friedman DJ.
J Interv Card Electrophysiol. 2023 Sep;66(6):1315-1316. doi: 10.1007/s10840-023-01506-y. Epub 2023 Feb 16.
Appropriate implantable cardioverter-defibrillator interventions in cardiac resynchronization therapy-defibrillator (CRT-D) patients undergoing device replacement: time to downgrade from CRT-D to CRT-pacemaker? Insights from real-world clinical practice in the DECODE CRT-D analysis.
Narducci ML, Biffi M, Ammendola E, Vado A, Campana A, Potenza DR, Iori M, Zanon F, Zacà V, Zoni Berisso M, Bertini M, Lissoni F, Bandini A, Malacrida M, Crea F.
Europace. 2018 Sep 1;20(9):1475-1483. doi: 10.1093/europace/eux323.
A devices' game of thrones: cardiac resynchronization therapy vs. pacemaker.
Moura-Ferreira S, Gonçalves H, Oliveira M, Primo J, Fonseca P, Ribeiro J, Santos E, Pelicano N, Martins D, Gama V.
Europace. 2017 Dec 1;19(12):2042-2046. doi: 10.1093/europace/eux081.
Case presentation: implantation of cardiac resynchronization therapy pacemaker via the coronary sinus in a patient with triple valve replacement.
Zheng C, Lin WQ, Lin YZ, Lian H, Liu ZR, Chen JH, Lin JF.
BMC Cardiovasc Disord. 2018 Feb 21;18(1):37. doi: 10.1186/s12872-018-0775-7.
Ampere Hour as a Predictor of Cardiac Resynchronization Defibrillator Pulse Generator Battery Longevity: A Multicenter Study.
Ellis CR, Dickerman DI, Orton JM, Hassan S, Good ED, Okabe T, Andriulli JA, Quan KJ, Greenspon AJ.
Pacing Clin Electrophysiol. 2016 Jul;39(7):658-68. doi: 10.1111/pace.12831. Epub 2016 Mar 11.
Battery longevity of implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators: technical, clinical and economic aspects. An expert review paper from EHRA.
Boriani G, Merino J, Wright DJ, Gadler F, Schaer B, Landolina M.
Europace. 2018 Dec 1;20(12):1882-1897. doi: 10.1093/europace/euy066.
Replacement of implantable cardioverter defibrillators and cardiac resynchronization therapy devices: results of the European Heart Rhythm Association survey.
Tilz R, Boveda S, Deharo JC, Dobreanu D, Haugaa KH, Dagres N.
Europace. 2016 Jun;18(6):945-9. doi: 10.1093/europace/euw157.
Clinical predictors of pocket hematoma after cardiac device implantation and replacement.
Ferretto S, Mattesi G, Migliore F, Susana A, De Lazzari M, Iliceto S, Leoni L, Bertaglia E.
J Cardiovasc Med (Hagerstown). 2020 Feb;21(2):123-127. doi: 10.2459/JCM.0000000000000914.
Effect of fibrotic capsule debridement during generator replacement on cardiac implantable electronic device infection risk.
Goldenberg GR, Barsheshet A, Bishara J, Kadmon E, Omelchencko A, Strasberg B, Golovchiner G.
J Interv Card Electrophysiol. 2020 Jun;58(1):113-118. doi: 10.1007/s10840-019-00581-4. Epub 2019 Jun 21.
